Current developments in the therapy of protozoan infections. - Wikidata - awgldk - TriplyDB

Current developments in the therapy of protozoan infections.

Current developments in the therapy of protozoan infections.

http://www.wikidata.org/entity/Q37883063

about

Functional expression of parasite drug targets and their human orthologs in yeast Antiprotozoal Nitazoxanide Derivatives: Synthesis, Bioassays and QSAR Study Combined with Docking for Mechanistic Insight.Identification of Tight-Binding Plasmepsin II and Falcipain 2 Inhibitors in Aqueous Extracts of Marine Invertebrates by the Combination of Enzymatic and Interaction-Based Assays.Development and validation of four Leishmania species constitutively expressing GFP protein. A model for drug discovery and disease pathogenesis studies.Yeast-based automated high-throughput screens to identify anti-parasitic lead compounds Microbial and fungal protease inhibitors--current and potential applications.Immunomodulatory effects of antimicrobial agents. Part II: antiparasitic and antifungal agents.In vitro antigiardial activity of the cysteine protease inhibitor E-64.4-Acetoxydolastane diterpene from the Brazilian brown alga Canistrocarpus cervicornis as antileishmanial agent.

P2860

Q28477338-2FFAA61D-C3A1-4FD0-BAFD-E6AE9B21087C Q30352841-3931C944-C7F5-4728-BAC0-EC7AFAAC8110 Q33612293-239206A0-6052-49AE-8B8D-DB82F5D1403A Q35047048-8E39066D-1D86-410E-8ACC-C536E0A54A0F Q36702409-C197DE69-F9B0-4E2E-AD4C-40DA32926063 Q37973268-9407E7E0-3EE4-4C4E-AA2B-EEE89E7AF30D Q37991390-5DD0CAC9-14DC-4871-89A3-CB6DB4591769 Q39247809-25A5045A-7954-40D2-B4B2-AECA40DC3B76 Q39552018-BFD42470-9F8A-4A1E-8982-192FE6703C9D

P2860

Current developments in the therapy of protozoan infections.

http://www.wikidata.org/entity/Q37883063

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current developments in the therapy of protozoan infections.

@en

Current developments in the therapy of protozoan infections.

@nl

type

label

Current developments in the therapy of protozoan infections.

@en

Current developments in the therapy of protozoan infections.

@nl

prefLabel

Current developments in the therapy of protozoan infections.

@en

Current developments in the therapy of protozoan infections.

@nl

P1433

Q37883063-3FE14E40-B070-4458-A904-7E3353D5A509

P1476

Q37883063-A5DEF2C1-01D5-4CB1-A6E5-5B434EEACABA

P2093

Q37883063-27B4282A-2DA6-417D-B360-053FF9EB9F8E

Q37883063-C057A2F2-20BB-4075-AC69-9AB29A746D59

P2860

Q37883063-00ECA338-AB96-4CD1-8595-D38428A6934C

Q37883063-03E548D0-912D-4871-8E12-9CC6466C211D

Q37883063-0EB6A3A8-0421-489A-9235-61C16D3E9B64

Q37883063-0FC0501F-FBC0-4512-9418-3F1F15C66751

Q37883063-11AEB448-6EED-4618-8E32-4ED1071977B5

Q37883063-13E57FE8-AB59-465B-BE57-B6BA1C404F13

Q37883063-155C4E7A-D136-4C41-ACF4-4C2C1F2B1E45

Q37883063-19EE5AF3-458E-42AA-82E9-8CDB15BB74ED

Q37883063-1D85DBCC-51E9-471D-93F9-6901158C676A

Q37883063-1F9E2964-213B-4FBB-9612-DC8CA165F85D

P304

Q37883063-A823D5D6-B436-4C92-9999-E2092E50A294

P31

Q37883063-F4C629F4-5C70-4467-BFDA-83E4118DD210

P356

Q37883063-7D866D9C-40E7-4755-911B-1902C0857D2F

P478

Q37883063-51B6C170-4851-468F-A8D3-EEBB34813D10

P577

Q37883063-E7664742-C762-414F-B91A-9D33B3B3BDF3

P5875

Q37883063-E6635113-9779-4524-8910-1991A884ED2B

P698

Q37883063-CF1E0DFF-EC2C-4CF8-AE93-673D519A1943

P932

Q37883063-1901A69F-BC08-471B-B187-A12D3EAA35B0

P356

1874104501105010004

P1433

The open medicinal chemistry journal

P1476

Current developments in the therapy of protozoan infections.

@en

P2093

Dianella Savoia

http://www.w3.org/2001/XMLSchema#string

Mario Zucca

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring

Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica

Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs

Large-scale differential proteome analysis in Plasmodium falciparum under drug treatment

Cellular uptake of the tat protein from human immunodeficiency virus

Opportunities and Challenges in Antiparasitic Drug Discovery

In silico drug discovery approaches on grid computing infrastructures.

Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.

Comparing highly efficacious antimalarial drugs.

Silencing cytokeratin 18 gene inhibits intracellular replication of Trypanosoma cruzi in HeLa cells but not binding and invasion of trypanosomes

P304

4-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874104501105010004

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51181306

http://www.w3.org/2001/XMLSchema#string

P698

21629507

http://www.w3.org/2001/XMLSchema#string

P932

3103884

http://www.w3.org/2001/XMLSchema#string